Amyloidosis relapsing after autologous stem cell transplantation treated with bortezomib: normalization of detectable serum-free light chains and reversal of tissue damage with improved suitability for transplant

被引：6
|
作者：
Brunvand, Mark W. [1 ]
Bitter, Mitchell [2 ]
机构：
[1] Rocky Mt Blood & Marrow Transplant Program, Denver, CO 80218 USA
[2] Unipath, Denver, CO USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷 / 03期
关键词：
SYSTEMIC AL AMYLOIDOSIS; CHEMOTHERAPY; SURVIVAL;
D O I：
10.3324/haematol.2009.013102
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：519 / 521
页数：3
相关论文
共 30 条
  • [21] Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation
    Moesbauer, Ulrike
    Ayuk, Francis
    Schieder, Heike
    Lioznov, Michael
    Zander, Axel R.
    Kroeger, Nicolaus
    HAEMATOLOGICA, 2007, 92 (02) : 275 - 276
  • [22] MATHEMATICAL MODEL OF SERUM FREE LIGHT CHAIN DECLINE IDENTIFIES A KINETIC PREDICTIVE MARKER OF SURVIVAL IN PATIENTS WITH MYELOMA TREATED WITH BORTEZOMIB, DEXAMETHASONE AND STEM CELL TRANSPLANTATION
    Heiblig, M.
    Lachenal, F.
    Karlin, L.
    You, B.
    HAEMATOLOGICA, 2013, 98 : 609 - 610
  • [23] The pre-ASCT serum albumin and pre-ASCT dFLC are prognostic markers in renal light chain amyloidosis patients treated with autologous stem cell transplantation
    Chen, Wencui
    Zhang, Yuanyuan
    Guo, Jinzhou
    Wu, Xiaomei
    Xu, Weiwei
    Liu, Zhihong
    Huang, Xianghua
    BONE MARROW TRANSPLANTATION, 2025,
  • [24] Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation
    Afrough, Aimaz
    Saliba, Rima M.
    Hamdi, Amir
    El Fakih, Riad
    Varma, Ankur
    Dinh, Yvonne T.
    Rondon, Gabriela
    Cornelison, A. Megan
    Shah, Nina D.
    Bashir, Qaiser
    Shah, Jatin J.
    Hosing, Chitra
    Popat, Uday
    Orlowski, Robert Z.
    Champlin, Richard E.
    Parmar, Simrit
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (08) : 1413 - 1417
  • [25] Early Serum Free Light Chain Response after High-Dose Melphalan and Stem Cell Transplantation Predicts Hematologic Response in AL Amyloidosis
    Furtado, Vanessa Fiorini
    Brauneis, Dina
    Sarosiek, Shayna
    Quillen, Karen
    Sanchorawala, Vaishali
    BLOOD, 2020, 136
  • [26] Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis
    Furtado, Vanessa Fiorini
    Brauneis, Dina
    Weinberg, Janice
    Elhassan, Noon
    Sloan, J. Mark
    Sanchorawala, Vaishali
    BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 306 - 308
  • [27] Early serum free light chain response after high-dose melphalan and stem cell transplantation predicts hematologic response in AL amyloidosis
    Vanessa Fiorini Furtado
    Dina Brauneis
    Janice Weinberg
    Noon Elhassan
    J. Mark Sloan
    Vaishali Sanchorawala
    Bone Marrow Transplantation, 2022, 57 : 306 - 308
  • [28] Early Adjuvant Treatment after Risk-Adapted Autologous Stem Cell Transplant for Systemic Light-Chain Amyloidosis: Increased Hospitalizations and Impaired Immune Recovery but Improved Responses and Overall Survival
    Hoffman, James E.
    Hassoun, Hani
    Landau, Heather
    Hoover, Elizabeth
    Cohen, Adam
    Nimer, Stephen
    Comenzo, Raymond
    BLOOD, 2008, 112 (11) : 1143 - 1144
  • [29] Improved relapse free survival is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy for relapsed diffuse large B cell lymphoma (DLBCL) treated with autologous stem cell transplantation
    Dickinson, Michael J.
    Hoyt, Rosemary
    Roberts, Andrew
    Grigg, Andrew
    Seymour, John Francis
    Szer, Jeff
    Prince, H. Miles
    Ritchie, David
    BLOOD, 2007, 110 (11) : 360B - 360B
  • [30] Improved relapse free and overall survival is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy for relapsed diffuse large B-cell lymphoma treated with autologous stem cell transplantation
    Dickinson, M.
    Hoyt, R.
    Roberts, A.
    Grigg, A.
    Seymour, J. F.
    Prince, H. M.
    Szer, J.
    Ritchie, D.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S245 - S245
123